A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis

Clinical trial NCT00808977 · COMPLETED

Trial details

NCT number: NCT00808977
Sponsor: Palau Pharma S.L.U.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2008-12-01
Primary completion: 2010-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.